HEART ASSURE FOR DIABETES

A specialized screening package to assess heart health in diabetic patients. It includes tests to monitor cholesterol levels, blood sugar control, and other cardiovascular risk factors.

Also known asHeart Assure Panel For Diabetes Patients Heart Assure For Diabetes Heart Assure For Diabetes

Available via

Home Collection, Lab Visit

Contains

14 parameters

Earliest reports in

Same Day

Test details

HEART ASSURE FOR DIABETES Package in Mangaluru Overview

Preparations

No special preparations needed

Test included
HEART ASSURE FOR DIABETES includes 14 parameters

  • Fbs-fasting Blood Sugar(glucose)

  • Creatinine

  • Hba1c
  • Estimated Average Glucose(eag)

  • N-terminal Pro B-type Natriuretic Peptide

  • Cholesterol, Total
  • Triglycerides
  • Hdl Cholesterol
  • Cholesterol Ldl
  • Non Hdl Cholesterol
  • Very Low Density Lipoprotein
  • Chol/hdl Ratio
  • Ldl/hdl Ratio

  • High Sensitive Troponin-i
Frequently Asked Questions

A. Anyone can test for their sugar levels and heart health through this panel.

 

B. Pre-diabetic / Diabetic patients having high blood sugar / HbA1c levels (Type 2 Diabetes) should ideally test themselves with this panel periodically. This panel will not only provide status of their diabetes but also give valuable information of their heart health.

It is a known fact that patients with uncontrolled / high diabetes are at high risk for developing Cardio Vascular Disease (Cardio Vascular Disease)1. Testing periodically for your heart health will help identify any risk for Cardio Vascular Disease that may be underlying & provide patients / doctors to take timely corrective action.

 

Reference

Einarson, T.R., Acs, A., Ludwig, C. et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 17, 83 (2018)

Most heart diseases develop silently. In most cases, it’s already too late when the symptoms surface. Periodic & timely testing may help patients identify a developing Cardio Vascular Disease, giving them time to take corrective actions (in conjunction with their doctor’s advice).

 

Heart Assure (hsTnI)

Elevated levels indicates subclinical Myocardial injury2

NT-Pro BNP

Elevated levels indicates Heart Failure - overload of blood in either chamber of the heart, cause of wall stress in ventricles3

Lipid Profile

Elevation in lipid values may assist in correlation for risk assessment of CAD1,4

HbA1c & Glucose (F)

High levels of HbA1c & glucose may co-relate with CAD complications

Creatinine

Rule out false positive hsTnI levels due to possible renal disease / aliment5

 

References

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83–83.

 

Luis Leite, Pedro Matos, Antonio Leon-Justel. High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention. 30 November 2022 DOI 10.3389/fcvm.2022.1054959

 

WolskE et al. Circulation (2017) doi: https://doi.org/10.1161/CIRCULATIONAHA.117.029503

 

Arun Kumar and Brijesh Sathian. Correlation between lipid profile and troponin I test results in patients with chest pain in Nepal. Asian Pac J Trop Biomed. 2013 Jun; 3(6): 487–491. doi: 10.1016/S2221-1691(13)60101-X

 

Kiran Sebastian, MD, Alexander Wester, BS, Anupama Kottam, MD and Ayman O. Soubani, MD. Cleveland Clinic Journal of Medicine April 2018, 85 (4) 274-277; DOI: https://doi.org/10.3949/ccjm.85a.17011. Are serum troponin levels elevated in conditions other than acute coronary syndrome?

Test code

10507

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer1 ML
Fasting Plasma Fl.Grey Vacutainer.5 ML
SerumYellow Vacutainer14 ML
SmearOthers

Specimen stability information

Edta Whole Blood, Fasting Plasma Fl., Serum, Smear

Collection instructions

Age+Gender+Clinical history required. samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration

Specimen rejection criteria

Test run frequency

'

Turn around time

Same Day

Performing locations

Department

  • Haemotology
  • Bio Chemistry
  • Eia-endocrinology
  • Endocrinology

CPT and Loinc codes

HEART ASSURE FOR DIABETES

3499